NASDAQ:TRUP - Trupanion Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $98.60
  • Forecasted Upside: -13.36 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.26 (0.23%)

This chart shows the closing price for TRUP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Trupanion Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TRUP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TRUP

Analyst Price Target is $98.60
▼ -13.36% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Trupanion in the last 3 months. The average price target is $98.60, with a high forecast of $150.00 and a low forecast of $43.00. The average price target represents a -13.36% upside from the last price of $113.81.

This chart shows the closing price for TRUP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 investment analysts is to buy stock in Trupanion. This rating has held steady since January 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/5/2021Evercore ISIInitiated CoverageOutperform$100.00High
2/11/2021Lake Street CapitalBoost Price TargetBuy$85.00 ➝ $150.00Low
2/11/2021Canaccord GenuityBoost Price TargetBuy$140.00 ➝ $150.00Low
11/2/2020Canaccord GenuityBoost Price TargetBuy$88.00 ➝ $95.00High
10/30/2020Lake Street CapitalBoost Price Target$67.00 ➝ $85.00High
8/10/2020GuggenheimDowngradeBuy ➝ NeutralLow
8/5/2020Canaccord GenuityBoost Price TargetBuy$58.00 ➝ $62.00High
8/5/2020Lake Street CapitalBoost Price TargetPositive ➝ Buy$50.00 ➝ $67.00High
8/5/2020Northland SecuritiesDowngradeOutperform ➝ Market Perform$42.00 ➝ $50.00High
7/30/2020Stifel NicolausBoost Price TargetHold$33.00 ➝ $43.00Low
6/25/2020Northland SecuritiesInitiated CoverageBuy$42.00Medium
6/15/2020Royal Bank of CanadaReiterated RatingBuy$40.00High
6/9/2020Northland SecuritiesInitiated CoverageBuy$42.00Low
5/1/2020Lake Street CapitalReiterated RatingBuy$50.00Low
5/1/2020Royal Bank of CanadaBoost Price TargetOutperform$39.00 ➝ $40.00High
5/1/2020Northland SecuritiesReiterated RatingBuy$35.00High
4/27/2020Royal Bank of CanadaReiterated RatingBuy$39.00High
4/8/2020Royal Bank of CanadaReiterated RatingBuy$39.00High
4/6/2020Northland SecuritiesReiterated RatingBuy$35.00High
3/2/2020Canaccord GenuityReiterated RatingBuy$44.00High
2/14/2020Lake Street CapitalBoost Price TargetBuy$46.00 ➝ $50.00Low
2/14/2020Canaccord GenuityReiterated RatingBuy$44.00High
2/14/2020Raymond JamesDowngradeOutperform ➝ Market PerformHigh
1/8/2020Stifel NicolausDowngradeBuy ➝ Hold$32.00 ➝ $38.00High
11/18/2019GuggenheimBoost Price TargetBuy$35.00 ➝ $36.00Low
11/6/2019Northland SecuritiesReiterated RatingBuy$40.00High
10/11/2019Craig HallumSet Price TargetHold$20.00Low
8/16/2019Craig HallumDowngradeBuy ➝ Hold$29.00High
7/31/2019Royal Bank of CanadaSet Price TargetBuy$38.00Low
7/31/2019Northland SecuritiesReiterated RatingBuy$40.00High
5/23/2019GuggenheimInitiated CoverageBuy ➝ Buy$35.00High
5/14/2019Northland SecuritiesInitiated CoverageBuy$40.00High
11/13/2018Canaccord GenuityReiterated RatingBuy$43.00High
10/2/2018CL KingUpgradeNeutral ➝ BuyLow
9/6/2018Raymond JamesInitiated CoverageOutperform ➝ Outperform$46.00High
8/3/2018Lake Street CapitalReiterated RatingBuy$41.00 ➝ $46.00Medium
8/3/2018CowenBoost Price TargetOutperform ➝ Positive$41.00 ➝ $47.00Medium
8/3/2018Royal Bank of CanadaBoost Price TargetOutperform$44.00Medium
8/3/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$40.00 ➝ $43.00Medium
8/3/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$40.00 ➝ $46.00Medium
7/19/2018Craig HallumInitiated CoverageBuy$55.00High
7/10/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$34.00 ➝ $40.00Low
5/2/2018Canaccord GenuityReiterated RatingBuy$40.00Medium
2/14/2018Lake Street CapitalBoost Price TargetBuy ➝ Buy$32.00 ➝ $41.00High
2/14/2018CowenReiterated RatingOutperform$32.00 ➝ $38.00High
2/14/2018Stifel NicolausReiterated RatingBuy ➝ Buy$33.00 ➝ $34.00High
2/8/2018Northland SecuritiesReiterated RatingBuy$38.00High
11/21/2017CL KingInitiated CoverageNeutralN/A
10/31/2017Canaccord GenuityReiterated RatingBuy$29.00 ➝ $35.00N/A
8/2/2017Canaccord GenuityBoost Price TargetBuy$28.00 ➝ $29.00Medium
8/2/2017CowenReiterated RatingOutperform$19.00 ➝ $28.00High
8/2/2017Stifel NicolausReiterated RatingBuy ➝ Buy$18.00 ➝ $24.00High
8/2/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$19.00 ➝ $26.00High
7/14/2017CowenReiterated RatingBuy$19.00Low
7/6/2017Northland SecuritiesSet Price TargetBuy$23.00Low
5/26/2017Northland SecuritiesInitiated CoverageOutperform ➝ Outperform$22.75High
11/3/2016Royal Bank of CanadaReiterated RatingBuy$18.00N/A
9/20/2016Royal Bank of CanadaSet Price TargetBuy$18.00N/A
8/4/2016Canaccord GenuityReiterated RatingBuy$19.00N/A
8/3/2016Royal Bank of CanadaReiterated RatingOutperform$14.00 ➝ $18.00N/A
8/3/2016Stifel NicolausBoost Price TargetBuy$17.00 ➝ $20.00N/A
(Data available from 7/28/2016 forward)
Trupanion logo
Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members and contracts include multiple pets. The company was founded by Darryl Rawlings in January 2000 and is headquartered in Seattle, WA.
Read More

Today's Range

Now: $113.81
Low: $111.01
High: $114.16

50 Day Range

MA: $102.47
Low: $75.84
High: $120.29

52 Week Range

Now: $113.81
Low: $48.83
High: $126.53


229,492 shs

Average Volume

374,089 shs

Market Capitalization

$4.56 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Trupanion?

The following Wall Street sell-side analysts have issued research reports on Trupanion in the last twelve months: Canaccord Genuity, Evercore ISI, Guggenheim, Lake Street Capital, Northland Securities, Stifel Nicolaus, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for TRUP.

What is the current price target for Trupanion?

5 Wall Street analysts have set twelve-month price targets for Trupanion in the last year. Their average twelve-month price target is $98.60, suggesting a possible downside of 13.4%. Canaccord Genuity has the highest price target set, predicting TRUP will reach $150.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $43.00 for Trupanion in the next year.
View the latest price targets for TRUP.

What is the current consensus analyst rating for Trupanion?

Trupanion currently has 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TRUP will outperform the market and that investors should add to their positions of Trupanion.
View the latest ratings for TRUP.

What other companies compete with Trupanion?

How do I contact Trupanion's investor relations team?

Trupanion's physical mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider's listed phone number is (888) 733-2685 and its investor relations email address is [email protected] The official website for Trupanion is